Terms: = Ovarian cancer AND QKI, Hqk, 9444, ENSG00000112531, Q96PU8, QK3, DKFZp586I0923, QK
4 results:
1. Contrast-enhanced ultrasound for differential diagnosis of malignant and benign ovarian tumors: systematic review and meta-analysis.
Ma X; Zhao Y; Zhang B; Ling W; Zhuo H; Jia H; Li P
Ultrasound Obstet Gynecol; 2015 Sep; 46(3):277-83. PubMed ID: 25644038
[TBL] [Abstract] [Full Text] [Related]
2. Tumor microenvironment-associated modifications of alternative splicing.
Brosseau JP; Lucier JF; Nwilati H; Thibault P; Garneau D; Gendron D; Durand M; Couture S; Lapointe E; Prinos P; Klinck R; Perreault JP; Chabot B; Abou-Elela S
RNA; 2014 Feb; 20(2):189-201. PubMed ID: 24335142
[TBL] [Abstract] [Full Text] [Related]
3. qki-mediated alternative splicing of the histone variant MacroH2A1 regulates cancer cell proliferation.
Novikov L; Park JW; Chen H; Klerman H; Jalloh AS; Gamble MJ
Mol Cell Biol; 2011 Oct; 31(20):4244-55. PubMed ID: 21844227
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.
Cochrane DR; Spoelstra NS; Howe EN; Nordeen SK; Richer JK
Mol Cancer Ther; 2009 May; 8(5):1055-66. PubMed ID: 19435871
[TBL] [Abstract] [Full Text] [Related]
